Nanotech Probes: A Revolution in Cancer Diagnosis

3Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Recent advances in nanotechnologies for cancer diagnosis and treatment have received considerable attention worldwide. Nanoparticles are being used to create nanodrugs and probes to diagnose and treat a variety of diseases, including cancer. Nanomedicines have unique advantages, such as increased surface-to-volume ratios, which enable them to interact with, absorb, and deliver small biomolecules to a very specific target, thereby improving the effectiveness of both probes and drugs. Nanoprobe biotechnology also plays an important role in the discovery of novel cancer biomarkers, and nanoprobes have become an important part of early clinical diagnosis of cancer. Various organic and inorganic nanomaterials have been developed as biomolecular carriers for the detection of disease biomarkers. Thus, we designed this review to evaluate the advances in nanoprobe technology in tumor diagnosis.

Cite

CITATION STYLE

APA

Zhang, Q., Hou, K., Chen, H., Zeng, N., & Wu, Y. (2022, July 7). Nanotech Probes: A Revolution in Cancer Diagnosis. Frontiers in Oncology. Frontiers Media S.A. https://doi.org/10.3389/fonc.2022.933125

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free